Blocking Interleukin-1 as a Novel Therapeutic Strategy for Secondary Prevention of Cardiovascular Events

Antonio Abbate, Benjamin W. Van Tassell, Giuseppe G.L. Biondi-Zoccai
  • BioDrugs, August 2012, Springer Science + Business Media
  • DOI: 10.2165/11631570-000000000-00000

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Prof. Giuseppe Biondi-Zoccai